Page last updated: 2024-09-03

glycyl-histidyl-arginyl-proline and sb 334867-a

glycyl-histidyl-arginyl-proline has been researched along with sb 334867-a in 1 studies

Compound Research Comparison

Studies
(glycyl-histidyl-arginyl-proline)
Trials
(glycyl-histidyl-arginyl-proline)
Recent Studies (post-2010)
(glycyl-histidyl-arginyl-proline)
Studies
(sb 334867-a)
Trials
(sb 334867-a)
Recent Studies (post-2010) (sb 334867-a)
17033400235

Protein Interaction Comparison

ProteinTaxonomyglycyl-histidyl-arginyl-proline (IC50)sb 334867-a (IC50)
Orexin receptor type 1Homo sapiens (human)0.04

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cone, JJ; McCutcheon, JE; Roitman, MF1

Other Studies

1 other study(ies) available for glycyl-histidyl-arginyl-proline and sb 334867-a

ArticleYear
Ghrelin acts as an interface between physiological state and phasic dopamine signaling.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014, Apr-02, Volume: 34, Issue:14

    Topics: Action Potentials; Animals; Benzoxazoles; Dopamine; Dose-Response Relationship, Drug; Fasting; Feeding Behavior; Ghrelin; Hypothalamic Area, Lateral; Intracellular Signaling Peptides and Proteins; Male; Naphthyridines; Neural Pathways; Neuropeptides; Nucleus Accumbens; Oligopeptides; Orexins; Rats; Rats, Sprague-Dawley; Signal Transduction; Urea; Ventral Tegmental Area; Wakefulness

2014